Treatments for HSV-2 infections include acyclovir, famciclovir, and valacyclovir. The current CDC recommended options for suppressive therapy of recurrent HSV-2 genital herpes are as follows:
Valacyclovir at 500 mg orally once a day (Valacyclovir at 500 mg once a day might be less effective than other valacyclovir or acyclovir dosing regimens for persons who have frequent recurrences.)
Valacyclovir at 1 gm orally once a day
Acyclovir at 400 mg orally 2 times per day
Famciclovir at 250 mg orally 2 times per day
Penciclovir is a DNA polymerase inhibitor in HSV-1 and HSV-2, with only topical preparations suited for herpes labialis available. Pritelivir has potent and resistance-breaking antiviral activity against HSV-1 and HSV-2 and is being developed for the treatment of acyclovir-resistant and dual-resistant mucocutaneous infections in immune-compromised patients. The therapy has been limited to treating short-term genital herpetic infections.
Learn more about valacyclovir.
This Fast Five Quiz was excerpted and adapted from the Medscape articles Herpes Simplex, Valacyclovir, and Bell Palsy.
Follow Medscape on Facebook, Twitter, Instagram, and YouTube
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Michael Stuart Bronze. Fast Five Quiz: Herpes Simplex Virus - Medscape - Sep 06, 2022.
Comments